BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang X, Qin Y, Wan X, Liu H, Lv C, Ruan W, He L, Lu L, Guo X. Rosuvastatin exerts anti-atherosclerotic effects by improving macrophage-related foam cell formation and polarization conversion via mediating autophagic activities. J Transl Med 2021;19:62. [PMID: 33568202 DOI: 10.1186/s12967-021-02727-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu C, Xiao K, Xie L. Progress in preclinical studies of macrophage autophagy in the regulation of ALI/ARDS. Front Immunol 2022;13:922702. [DOI: 10.3389/fimmu.2022.922702] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Li B, Ji Y, Yi C, Wang X, Liu C, Wang C, Lu X, Xu X, Wang X. Rutin Inhibits Ox-LDL-Mediated Macrophage Inflammation and Foam Cell Formation by Inducing Autophagy and Modulating PI3K/ATK Signaling. Molecules 2022;27:4201. [DOI: 10.3390/molecules27134201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Tang YQ, Li ZW, Feng YF, Yang HQ, Hou CL, Geng C, Yang PR, Zhao HM, Wang J. MK2206 attenuates atherosclerosis by inhibiting lipid accumulation, cell migration, proliferation, and inflammation. Acta Pharmacol Sin 2022;43:897-907. [PMID: 34316032 DOI: 10.1038/s41401-021-00729-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Tian H, Wang T, Zhang Y, Pan T, Yao S, Yu H, Ma K, Wang S. Astragaloside IV protects against C/EBP homologous protein-mediated apoptosis in oxidized low-density lipoprotein-treated macrophages by promoting autophagy. Eur J Pharmacol 2022;923:174912. [PMID: 35339476 DOI: 10.1016/j.ejphar.2022.174912] [Reference Citation Analysis]
5 Qin X, He W, Yang R, Liu L, Zhang Y, Li L, Si J, Li X, Ma K. Inhibition of Connexin 43 reverses ox-LDL-mediated inhibition of autophagy in VSMC by inhibiting the PI3K/Akt/mTOR signaling pathway. PeerJ 2022;10:e12969. [DOI: 10.7717/peerj.12969] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Hafiane A, Daskalopoulou SS. Targeting the Residual Cardiovascular Risk by Specific Anti-inflammatory Interventions as a Therapeutic Strategy in Atherosclerosis. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106157] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Guo H, Wei D, Liu R, Zhang C, Jiang S, Wang W, Hu H, Shen L, Liang X. A novel therapeutic strategy for atherosclerosis: autophagy-dependent cholesterol efflux. J Physiol Biochem. [DOI: 10.1007/s13105-021-00870-5] [Reference Citation Analysis]